DETECT Fentanyl and Xylazine Act of 2024

Bill 118 hr 8663, also known as the DETECT Fentanyl and Xylazine Act of 2024, is a piece of legislation introduced in the US Congress with the aim of addressing the growing concerns surrounding the use and distribution of fentanyl and xylazine in the United States.

Fentanyl is a powerful synthetic opioid that is significantly more potent than other opioids, such as heroin and morphine. It has been linked to a sharp increase in overdose deaths in recent years, leading to a public health crisis. Xylazine, on the other hand, is a veterinary sedative that has been increasingly used as a cutting agent in illicit drugs, including fentanyl.

The DETECT Fentanyl and Xylazine Act of 2024 seeks to combat the spread of these dangerous substances by implementing a series of measures. These measures include increasing funding for law enforcement agencies to detect and intercept shipments of fentanyl and xylazine, enhancing penalties for individuals involved in the trafficking of these substances, and providing resources for addiction treatment and prevention programs. Additionally, the bill calls for the establishment of a national database to track the distribution of fentanyl and xylazine, as well as the creation of a public awareness campaign to educate the public about the dangers of these substances. Overall, the DETECT Fentanyl and Xylazine Act of 2024 aims to address the growing threat posed by fentanyl and xylazine in the United States through a comprehensive approach that combines law enforcement efforts, prevention initiatives, and treatment resources.